Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
CytoSorbents Achieves Record Total Revenue and CytoSorb Sales in the Second Quarter 2018
-
CytoSorbents Reports Strong First Quarter 2018 Financial Results
-
CytoSorbents Continues Strong Trajectory of Growth in the Third Quarter 2017
-
Pre-Open Movers 03/31: (SORL) (BBRY) (BDSI) Higher; (DRIO) (BLRX) (CTSO) Lower (more...)
-
After-Hours Stock Movers 03/30: (AKTX) (VJET) (HIIQ) Higher; (DRIO) (BLRX) (CTSO) Lower (more...)
-
Unusual 11 Mid-Day Movers 10/5: (CPRX) (CRBP) (UEPS) Higher; (IMMU) (AZZ) (CTSO) Lower
-
CytoSorbents Achieves Fourth Consecutive Quarter of Record CytoSorb® Sales
-
CytoSorbents to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference

